These include POCTs for cardiovascular diseases (cholesterol, NT-pro-BNP), diabetes mellitus (HbA1c and glucose), kidney disease (microalbuminuria), blood coagulation (INR and D-dimers for deep vein thrombosis and pulmonary embolism), myocardial damage (heart-type fatty acid binding protein (H-FABP), troponin, CK-MB). This evidence concerns the gene FABP3 and pulmonary embolism.